Advertisement Search POZ Search 232 results found Advanced Search #ribavirin A collection of content all about ribavirin. Adding Sovaldi and Ribavirin to Retreatment With Mavyret Beats Hep C Mar 21, 2018: Those for whom Mavyret did not work the first time had a high cure rate with this intensified retreatment regimen. Hepatitis C Treatments Are Safe and Effective for Seniors Oct 28, 2019: The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable. Sovaldi & Ribavirin Is Effective for HIV/HCV Population Mar 24, 2014: Sovaldi and ribavirin cured 75 percent of those with genotype 1 of hepatitis C in a recent trial Yes, Kids Can Get the New Coronavirus Mar 12, 2020: Children can contract the virus, although they usually have no symptoms or mild illness. Sofosbuvir and Ribavirin Fare Well Among HIV-HCV Coinfected Nov 4, 2013: Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus. Hepatitis C Drugs Show Promise Against New Coronavirus Jul 12, 2020: Sofosbuvir and daclatasvir were linked to faster recovery and improved survival in studies in Iran. Reyataz HIV Medication May 11, 2020: Reyataz is a protease inhibitor HIV Medication. Reyataz was approved by the FDA in 2003. Prezista HIV Medication May 11, 2020: Prezista is a protease inhibitor HIV Medication. Prezista was approved by the FDA in October 2008. Real-World Hepatitis C Cure Rates Are Excellent in Europeans With HIV Apr 24, 2018: In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C. Hep C Treatment Tied to Lower Risk of Liver Cancer and Death From Any Cause Apr 8, 2019: Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals. Epclusa Is Broadly Effective Against Hep C in Real-World Use Dec 5, 2018: A recent study of people in British Columbia found, however, that people who inject drugs had lower cure rates. Sovaldi and Ribavirin Cure High Rates of Those With HIV & Hep C Jul 22, 2014: Sovaldi (sofosbuvir) and ribavirin cured between 84 percent and 91 percent of people coinfected with HIV and genotypes 1 through 4 of hepatiti... Pharmacist-Driven Hep C Treatment Sees Good Cure Rates Jul 22, 2019: Pharmacists oversaw the delivery of hepatitis C treatment in a recent study. Epclusa Is Highly Effective at Treating Genotype 3 of Hepatitis C Jul 5, 2018: In a recent study, even the presence of viral mutations associated with resistance to treatment did not affect the cure rate. PSI-7977, Peg-Interferon, Ribavirin Combo Shines in Genotype 1 Hep C Study Nov 9, 2011: Combining Pharmasset’s once-daily experimental nucleotide analog PSI-7977 with pegylated interferon and ribavirin cured 91 percent of 47 peopl... How Well Do Docs Manage Potential Conflicts Between Hep C and HIV Meds? Apr 9, 2018: A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions. In Very Rare Cases, Some Hep C May Remain After a Cure Sep 25, 2019: However, the presence of such persistent virus has not been found to be associated with liver damage. AbbVie’s Viekira Is Likely Safe for Kidneys in Those With HIV and Hep C Mar 27, 2018: A recent study analyzed kidney parameters among those with HIV who were treated for hep C with the regimen. Eight Weeks of Technivie Is Highly Effective in Treating Hepatitis C Jun 13, 2018: This was among a small group of people who contracted the virus within one year, most of whom had HIV as well. 1 2 3 4 5 6 7 8 9 10 11 ... 12 Next Advertisement Hot topics Forums: Support and discussion Blogs: The community speaks POZ Stories: Get inspired Magazine: Search the archives HIV: The Basics Recursos de VIH/SIDA en Español AIDS Is Everyday Ask POZ